Mumbai : Gujarat Based GSP Crop Science Limited has fixed the price band of Rs 304/- to Rs 320/- per Equity Share of face value ₹ 10/- each for its maiden initial public offer.

The Initial Public Offering (“IPO” or “Issue”) of the Company will open on Monday, March 16, 2026, for subscription and close on Wednesday, March 18, 2026.

Investors can bid for a minimum of 46 Equity Shares and in multiples of 46 Equity Shares thereafter. Equity shares outstanding as on date 39,018,750 Equity Shares of Rs 10 each.

The IPO is a fresh issue for Rs 240 crore and an offer-for-sale for up to 5,000,000 shares by promoter – Vilasben Vrajmohan Shah, Bhavesh Vrajmohan Shah, and Kappa Trust.

The proceeds from the fresh issue to the extent of Rs 170 crore will be used for repayment or pre-repayment of all or a portion of certain outstanding borrowings availed by the company, and general corporate purposes.

GSP Crop Science is a research-driven agrochemical company, specializing in the development and manufacturing of insecticides, herbicides, fungicides and plant growth regulators in India, with over 40 years of experience in the agrochemical industry.

It provides its customers with crop protection solutions designed to support farmers in maximizing productivity and achieving optimal agricultural output. As of September 30, 2025 the company has received 524 registrations across formulations and technical for agrochemicals manufactured by it.

The company’s revenue from operations was Rs 844.2 crore for the six months ended September 30, 2025 and its net profit was Rs 81 crore. Its revenue from operations was Rs 1,287.38 crore during FY25 as against Rs 1,203.3 crore during FY23. Its net profit was Rs 81.4 crore during FY25 as against Rs 17.5 crore during FY23.

Equirus Capital Private Limited and Motilal Oswal Investment Advisors Limited are the book-running lead manager, and MUFG Intime India Private Limited is the registrar of the offer.

The Offer is being made through the book-building process, wherein not more than 50% of the net offer is allocated to qualified institutional buyers, and not more than 15% and 35% of the net offer is assigned to non-institutional bidders and retail individual bidders respectively.